Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
Universal Technical Institute Inc (NYSE: UTI) closed the day trading at $32.62 down -3.75% from the previous closing price of $33.89. In other words, the price has decreased by -$3.75 from its previous closing price. On the day, 0.85 million shares were traded. UTI stock price reached its highest trading level at $33.795 during the session, while it also had its lowest trading level at $32.38.
Ratios:
For a better understanding of UTI, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.66 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.04. For the most recent quarter (mrq), Quick Ratio is recorded 1.07 and its Current Ratio is at 1.07. In the meantime, Its Debt-to-Equity ratio is 0.87 whereas as Long-Term Debt/Eq ratio is at 0.79.
On July 25, 2024, Truist started tracking the stock assigning a Buy rating and target price of $22.
On January 10, 2024, Northland Capital started tracking the stock assigning a Outperform rating and target price of $16.Northland Capital initiated its Outperform rating on January 10, 2024, with a $16 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 27 ’25 when Coliseum Capital Management, L sold 500,000 shares for $35.00 per share. The transaction valued at 17,500,000 led to the insider holds 2,716,267 shares of the business.
Hitchcock Todd A sold 27,500 shares of UTI for $917,471 on May 15 ’25. The EVP/COO now owns 80,521 shares after completing the transaction at $33.36 per share. On May 13 ’25, another insider, Brochick George W., who serves as the Director of the company, sold 6,000 shares for $31.84 each. As a result, the insider received 191,040 and left with 32,516 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UTI now has a Market Capitalization of 1774730240 and an Enterprise Value of 1964554624. As of this moment, Universal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 31.46, and their Forward P/E ratio for the next fiscal year is 30.61. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.85. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.27 while its Price-to-Book (P/B) ratio in mrq is 6.04. Its current Enterprise Value per Revenue stands at 2.51 whereas that against EBITDA is 17.986.
Stock Price History:
The Beta on a monthly basis for UTI is 1.58, which has changed by 0.981774 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, UTI has reached a high of $36.32, while it has fallen to a 52-week low of $15.06. The 50-Day Moving Average of the stock is 0.01%, while the 200-Day Moving Average is calculated to be 26.86%.
Shares Statistics:
Over the past 3-months, UTI traded about 817.69K shares per day on average, while over the past 10 days, UTI traded about 680380 shares per day. A total of 54.41M shares are outstanding, with a floating share count of 50.26M. Insiders hold about 7.62% of the company’s shares, while institutions hold 87.18% stake in the company. Shares short for UTI as of 1749772800 were 2329777 with a Short Ratio of 2.85, compared to 1747267200 on 1596255. Therefore, it implies a Short% of Shares Outstanding of 2329777 and a Short% of Float of 5.050000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0The stock’s 5-year Average Dividend Yield is 3.72.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $1.23, with 1 analysts recommending between $1.23 and $1.23.
Revenue Estimates
6 analysts predict $200.01M in revenue for the current quarter. It ranges from a high estimate of $201.96M to a low estimate of $196.9M. As of the current estimate, Universal Technical Institute Inc’s year-ago sales were $177.46MFor the next quarter, 6 analysts are estimating revenue of $220.48M. There is a high estimate of $221M for the next quarter, whereas the lowest estimate is $219.2M.
A total of 6 analysts have provided revenue estimates for UTI’s current fiscal year. The highest revenue estimate was $831.2M, while the lowest revenue estimate was $825M, resulting in an average revenue estimate of $829.38M. In the same quarter a year ago, actual revenue was $732.69MBased on 6 analysts’ estimates, the company’s revenue will be $896.73M in the next fiscal year. The high estimate is $907.77M and the low estimate is $886M.
